Related Experiment Videos
Gram-negative bacterial sepsis and the sepsis syndrome
The Urologic Clinics of North America
|December 10, 1999
Abstract:
Gram-negative sepsis syndrome is an increasingly common complication in medical and surgical patients. The molecular and cellular mechanisms underlying this dreaded complication are yielding to investigation. These studies have led to a multiplicity of targets for novel therapies. Despite highly promising results in many animal studies, clinical studies have been disappointing.
Insights
Gram-negative sepsis is a growing concern in healthcare. While research reveals many therapeutic targets, clinical treatments show disappointing results despite promising animal study findings.
Area of Science:
- Critical care medicine
- Infectious diseases
- Molecular biology
Background:
- Gram-negative sepsis is a frequent and severe complication in both medical and surgical patients.
- The underlying molecular and cellular mechanisms of sepsis are under active investigation.
- Numerous potential therapeutic targets have been identified through ongoing research.
Purpose of the Study:
- To investigate the molecular and cellular mechanisms of Gram-negative sepsis.
- To identify novel therapeutic targets for sepsis treatment.
- To evaluate the translation of promising animal study results into clinical efficacy.
Main Methods:
- Review of current molecular and cellular investigations into sepsis.
- Analysis of identified therapeutic targets for sepsis.
- Comparison of outcomes from animal model studies versus human clinical trials.
Main Results:
- Significant progress has been made in understanding sepsis pathogenesis at the molecular and cellular levels.
- A multitude of potential therapeutic targets have emerged from preclinical research.
- Clinical trials have largely failed to demonstrate the efficacy suggested by animal studies.
Conclusions:
- Despite advances in understanding sepsis mechanisms, effective clinical treatments remain elusive.
- The discrepancy between animal study success and clinical trial failure highlights challenges in sepsis therapy development.
- Further research is needed to bridge the gap between preclinical findings and successful patient outcomes in Gram-negative sepsis.